Pharming Group N.V. (LON:0QCO)

Pharming Group Statistics

Total Valuation

Pharming Group has a market cap or net worth of GBP 775.91 million. The enterprise value is 749.74 million.

Market Cap	775.91M
Enterprise Value	749.74M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	685.15M
Shares Outstanding	n/a
Shares Change (YoY)	-2.65%
Shares Change (QoQ)	-26.83%
Owned by Insiders (%)	2.77%
Owned by Institutions (%)	20.74%
Float	666.17M

Valuation Ratios

The trailing PE ratio is 2,730.29 and the forward PE ratio is 33.71.

PE Ratio	2,730.29
Forward PE	33.71
PS Ratio	2.88
PB Ratio	3.94
P/TBV Ratio	8.04
P/FCF Ratio	19.78
P/OCF Ratio	19.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.99, with an EV/FCF ratio of 19.12.

EV / Earnings	2,638.20
EV / Sales	2.79
EV / EBITDA	19.99
EV / EBIT	24.81
EV / FCF	19.12

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.49.

Current Ratio	3.16
Quick Ratio	2.39
Debt / Equity	0.49
Debt / EBITDA	2.55
Debt / FCF	2.48
Interest Coverage	2.90

Financial Efficiency

Return on equity (ROE) is 0.03% and return on invested capital (ROIC) is 0.08%.

Return on Equity (ROE)	0.03%
Return on Assets (ROA)	5.76%
Return on Invested Capital (ROIC)	0.08%
Return on Capital Employed (ROCE)	10.74%
Weighted Average Cost of Capital (WACC)	4.92%
Revenue Per Employee	667,104
Profits Per Employee	703
Employee Count	404
Asset Turnover	0.81
Inventory Turnover	0.57

Taxes

In the past 12 months, Pharming Group has paid 10.90 million in taxes.

Income Tax	10.90M
Effective Tax Rate	99.53%

Stock Price Statistics

The stock price has increased by +60.17% in the last 52 weeks. The beta is 0.23, so Pharming Group's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+60.17%
50-Day Moving Average	1.48
200-Day Moving Average	1.19
Relative Strength Index (RSI)	34.24
Average Volume (20 Days)	490,899

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharming Group had revenue of GBP 269.51 million and earned 284,185 in profits. Earnings per share was 0.00.

Revenue	269.51M
Gross Profit	242.30M
Operating Income	30.84M
Pretax Income	10.96M
Net Income	284,185
EBITDA	35.65M
EBIT	30.84M
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 123.62 million in cash and 97.40 million in debt, with a net cash position of 26.22 million.

Cash & Cash Equivalents	123.62M
Total Debt	97.40M
Net Cash	26.22M
Net Cash Per Share	n/a
Equity (Book Value)	196.88M
Book Value Per Share	0.39
Working Capital	141.12M

Cash Flow

In the last 12 months, operating cash flow was 39.68 million and capital expenditures -453,803, giving a free cash flow of 39.22 million.

Operating Cash Flow	39.68M
Capital Expenditures	-453,803
Free Cash Flow	39.22M
FCF Per Share	n/a

Margins

Gross margin is 89.90%, with operating and profit margins of 11.44% and 0.11%.

Gross Margin	89.90%
Operating Margin	11.44%
Pretax Margin	4.06%
Profit Margin	0.11%
EBITDA Margin	13.23%
EBIT Margin	11.44%
FCF Margin	14.55%

Dividends & Yields

Pharming Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.65%
Shareholder Yield	2.65%
Earnings Yield	0.04%
FCF Yield	5.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 5, 2013. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 5, 2013
Split Type	Reverse
Split Ratio	0.1

Scores

Pharming Group has an Altman Z-Score of 2.65 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.65
Piotroski F-Score	6